BioAge Labs BIOA
NASDAQ BIOA
$6.61 -0.20 (-2.94%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioAge Labs (BIOA) Price to Sales (2025 - 2026)

Updated

BioAge Labs' (BIOA) Price to Sales was 108.35 for Q2 2026, up 182.7% from 38.33 a year earlier and up 44.0% from the prior quarter.

Analysis

BioAge Labs (BIOA) Price to Sales (2025 - 2026) Analysis & Trends

For FY2025, Price to Sales at BioAge Labs was 54.99.

  • Per Business Quant data, the three quarters before Q2 2026 came in at 75.25 (Q1 2026), 54.99 (Q4 2025) and 35.63 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 BioAge Labs 302.59 Mn 302.59 Mn -14.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108.35
Mar 31, 2026 75.25
Dec 31, 2025 54.99
Sep 30, 2025 35.63
Jun 30, 2025 38.33
Mar 31, 2025 92.90
API Access

BioAge Labs Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=BIOA&period=max&api_key=YOUR_API_KEY